BioInnovation Institute Deploys €7.8 Million to Accelerate Six Danish Life-Science Startups Toward Market
The BioInnovation Institute (BII) announced an additional €7.8 million grant, split as €1.3 million per company, for six Danish spin‑outs working on antibody cancer therapies, AI‑powered ultrasound, inflammatory disease treatments, biological pest control, vaccine‑based immunotherapies, and waste‑to‑fuel technology. The funding builds on a prior €500 k grant each, bringing total support to €1.8 million per company and includes continued access to BII’s Copenhagen innovation platform.